DERMATOLOGISTS - Contact Congress Now votervoice.net/Shares/BIst4A…
2
70
Brad P. Glick, DO, MPH retweeted
I triple down on this
Brad P. Glick, DO, MPH retweeted
Congrats to this trio of immunologists!
BREAKING NEWS
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
Brad P. Glick, DO, MPH retweeted
Phase I trial led by Dr. Nicholas Gulati tested topical diphencyprone for cutaneous neurofibromas in NF1. Safe and well tolerated, but only 1 of 12 patients showed partial response. A key step toward future therapies.
🔗 bit.ly/4nXkQhN
@EmmaGuttman
Brad P. Glick, DO, MPH retweeted
If I told you I am making a tri-specific antibody that targets IL-1beta, IL-6, and TNF-alpha, every VC, investor, & pharma would run for the hills because of safety concerns.
Yet, vagus nerve stimulation can lower all of these cytokines safely and improve rheumatoid arthritis.
This is the sweet spot of neuroimmunology. Bending the therapeutic curve through immunologic tuning.
Brad P. Glick, DO, MPH retweeted
Lebrikizumab rapidly reduced IL-13–driven biomarkers and improved clinical outcomes in moderate-to-severe AD. This study by @emmaguttman and colleagues confirms IL-13 as a central driver of systemic inflammation and a prime target for precision therapy
🔗 doi.org/10.1007/s13555-025-0…
Brad P. Glick, DO, MPH retweeted
Today is a landmark moment in bioelectronic medicine and neuroimmunology. @KevinJTraceyMD and colleagues identified the inflammatory reflex over 25 years ago and now (today!) have delivered a FDA-approved device to treat autoimmunity. Viva la revolucion!
businesswire.com/news/home/2…
Brad P. Glick, DO, MPH retweeted
This is one of the most brutally honest dialogues I have had about peer review. Peer review is valuable, but why? I am not sure we ask this question enough. It shouldn’t be a mindless, perfunctory, legacy enterprise. It should clearly and maybe even quantifiably bring value. Listen to my hot 🔥 el fuego take.
Listen. Learn. Love it.
A lot of insights from @itchdoctor, who's already made it in TradSci, on how TradSci could possibly align with DeSci.
To all who listened to this, continue building for DeSci.
We're early; keep pushing the boundaries forward.
teapawt.org/i/spaces/1vOGwXWkaqWJB
such great news and warm congratulations!!!
Kim Lab trainees have had an incredible 2025!
Lydia Zamidar accepted into MSTP (MD/PhD).
Daniel Yassky @dmyassky accepted into MD.
Victoria Le accepted into MD.
Kelsey Auyeung @kelsey_auyeung matched into Dermatology.
Anna Trier @AnnaMTrier matched into Dermatology.
Our lab continues batting 1000! Stay tuned!
1
196
Brad P. Glick, DO, MPH retweeted
🚨 News Alert 🚨
The FDA just released an important update regarding benzene in benzoyl peroxide products (fda.gov/drugs/drug-safety-an…). See below for my thoughts and products to avoid:
Brad P. Glick, DO, MPH retweeted
It was a pleasure to reunite with great friends and colleagues at #AAD2025! Last Friday, our reception for Alumni and Friends of @MSHSDerm was an astonishing success, bringing ~500 dermatologists, and pharma members that celebrated our achievements with us. Thanks to all who attended! #dermtwitter #dermatology #NIH #Icahn #mountsinai #best
Brad P. Glick, DO, MPH retweeted
Hear from newly installed SOCS President @DrNadaE on the work of the #SkinofColorSociety and her vision for the future: hcplive.com/view/future-init… via @hcplive
Brad P. Glick, DO, MPH retweeted
If you look at what the American Academy of Dermatology Annual Meeting looks like today, and if I could show you what it looked like in 2015, you would not believe me. Imagine a world without abrocotinib, dupilumab, lebrikizumab, tralokinumab, ruxolitinib, upadacitinib, and nemolizumab. Imagine no one caring about atopic dermatitis, prurigo nodularis, urticaria, pruritus. That was 2015. Today, itch has literally transformed the field of dermatology completely. If this sounds hyperbolic to you, then you probably missed your exit in Orlando and spent this weekend at Magic Kingdom.
Dr. Brian S. Kim @itchdoctor gave an “Update on Itch and its Treatments” at the “Dermatology Review: General” session at #AAD2025 #Orlando
- IL-31 the “bell of the ball at AAD” and more were discussed. #research #neuroinflammation @EmmaGuttman
Brad P. Glick, DO, MPH retweeted
Had a great time at the 2025 American Academy of Dermatology Meeting.
I discussed the evolving landscape and new developments in chronic pruritus of unknown origin, atopic dermatitis, chronic spontaneous urticaria, & prurigo nodularis #AAD2025 #dermtwitter
Brad P. Glick, DO, MPH retweeted
Honored to be nominated for Vice-President elect of the AAD - I will
1. FIGHT FOR INFLATION-BASED MEDICARE REIMBURSEMENT
2. ADVOCATE FOR PRESERVING OF OUR SCOPE OF PRACTICE
3. ENSURE MISLEADING ADVERTISING IS COMBATTED
4. PROMOTE THE VALUE OF DERMATOLOGY
Brad P. Glick, DO, MPH retweeted
Standing room only: @EmmaGuttman presented “Atopic Dermatitis: An Evolving Success Story” at “Inflammatory Skin Diseases: The Translational Revolution” session, in which Dr. Guttman was the director.
#AAD2025 #Orlando
@IcahnMountSinai
Brad P. Glick, DO, MPH retweeted
As more drugs are developed for AD — Which drug for which patient? 💊 🔬❓
@EmmaGuttman discussed the Lancet article “Atopic Dematitis” with Dr. Christopher Bunick, at Practical Dermatology. See the video: bit.ly/EGuttmanADPracticalDe…
@IcahnMountSinai
Brad P. Glick, DO, MPH retweeted
I am excited to announce that dermatologist and dermatopathologist Dr. Elizabeth Newland will be joining the Department of Dermatology at Maryland @UMmedschool & @UMMC! #dermtwitter
Brad P. Glick, DO, MPH retweeted
Sensory neurons are both afferent and efferent and respond to many physical, inflammatory, and microbial stimuli. They also shape the scope and intensity of inflammation by acting on immune cells, stroma, epithelia, and even cancer.
Brad P. Glick, DO, MPH retweeted
The ACR’s Musculoskeletal Ultrasound Certification in Rheumatology (RhMSUS) program is the only recognized certification for musculoskeletal ultrasound, & it’s valid for 10 years. Join a growing list of RhMSUS designees, earn a new credential, & improve your patient care by becoming RhMSUS certified.
View the eligibility requirements, choose your pathway to determine your certification criteria, & be sure to register for the spring exam, taking place May 15-June 15, by March 31 → acr.tw/4h0ckL1




































